Latest Financial Results News

Lynch Group reports robust FY25 trading results, driven by strong Australian and Chinese markets, and sets optimistic full-year revenue and earnings guidance.

Norwood Systems has successfully delivered a crucial software milestone under a major telecom contract, while also reporting strong customer receipts that bolster its cash position.

Little Green Pharma invites shareholders to a detailed FY2025 financial results webinar, promising insights into profitability, revenue growth, and recent financing achievements.

Metcash Limited is consolidating its Independent Hardware Group and Total Tools Holdings into a single entity to strengthen its hardware business, while FY25 earnings are poised to slightly exceed market expectations.

Story-i Limited reported a significant AUD 24.17 million loss for FY2024, driven by the receivership and liquidation of its Indonesian Apple reseller business. The company is now focused on recapitalisation and securing new investments to revive operations.

QuickFee Limited has launched a A$1.5 million capital raising to fund expansion of its loan books in the US and Australia, following a quarter of record revenue and positive earnings before tax. The fintech also completed a major refinancing and revised its earnings guidance due to a credit impairment provision.

Metals X Limited has announced a pre-conditional voluntary cash partial offer to acquire up to 28% of Greentech Technology International Limited at HK$0.35 per share, aiming to increase its stake in the joint venture behind the Renison Tin Mine. The offer follows Greentech's failure to meet pre-conditions for a full takeover and comes amid ongoing trading suspension and delayed financial results.

Treasury Wine Estates faces a pivotal shift as RNDC ends its California distribution, prompting a strategic rethink amid a slightly lowered FY25 EBIT forecast.

Resimac Group Ltd has announced a special fully franked dividend of AUD 0.12 per share, signaling strong shareholder returns ahead of the mid-year payment date.

Fintech Chain Limited reported a 24% revenue increase to RMB55.9 million for FY2025 driven by new SaaS products, yet it remains in the red with a net loss of RMB4.8 million. The company has also applied for delisting from the ASX.

Amplia Therapeutics reports strong progress in its pancreatic cancer drug development, completing the ACCENT trial recruitment ahead of schedule and initiating a new US trial, while managing a $6.57 million loss for FY25.

Merchant House International Limited reported a 38% reduction in net loss for FY2025, driven by asset sales and operational wind-down. The company is moving towards divesting remaining assets, delisting from ASX, and winding up.